ABOUT US
Avsana Labs is a biotechnology startup and spin-out company from the University of Texas at Dallas (UTD) that seeks to improve viral diagnostic and blood-based biomarker testing using cutting-edge methodologies. We are following an accelerated path in bringing our technology to market, in collaboration with UTD and the University of Texas Southwestern Medical School (UTSW).
Avsana intends to enable a significant societal benefit by facilitating population-scale screening in rural areas, community clinics, and low-resource settings. The intention is to provide a significantly improved diagnostic technology, in terms of speed, accuracy, multiplex capability, and cost-effectiveness, for a range of diseases.
OUR TEAM
Avsana’s team includes experienced business executives and entrepreneurs, as well as researchers and technologists with experience in functional nanoparticle development, clinical studies, advance technologies for pathogen detection, and data analysis.
Zhenpeng Qin, PhD
Co-Founder and President
Dennis I. Robbins, PhD
Co-Founder and Chairman, Board of Directors
Matthew Amato, PhD Candidate
VP of Operations
Vinit Sheth, PhD
VP of Engineering
Nadine Pennington, MS
Co-Founder and Director of Operations
Jeffrey L. Kahn, MD-PhD
Chief Medical Officer and Chair, Scientific Advisory Board
Oren Eliezer, PhD
Advisory Board Member
Leonidas Bleris, PhD
Advisory Board Member